Brief: Nanoviricides Plans On Exploring Effectiveness Of NV-387 For Treatment Of Severe Acute Respiratory Infections Caused By Viruses
19/08/2024 12:46
Aug 19 (Reuters) - NanoViricides Inc NNVC.A :
* NANOVIRICIDES: PLANS ON EXPLORING EFFECTIVENESS OF NV-387
FOR
TREATMENT OF SEVERE ACUTE RESPIRATORY INFECTIONS CAUSED BY
VIRUSES
* NANOVIRICIDES: ANIL DIWAN VISITING WITH PROFESSIONALS FOR
DEVELOPING PHASE II CLINICAL TRIAL PLAN & CLINICAL PROTOCOL FOR
PHASE II CLINICAL TRIAL OF NV-387
Further company coverage: NNVC.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on NanoViricides,
See all newsExplainer: What do we know about the Bundibugyo strain of the Ebola virus?
Brief: anoViricides Signs Agreement for Orphan Drug Strategy of NV-387 for Mpox, Smallpox, and Measles
Brief: Nanoviricides Says NV-387 Shows Activity Against Measles Virus In Humanized Animal Model
Brief: Nanoviricides Co's Business Not Affected By Tariff Policies Of Us Government Or Corresponding Retaliatory Policies Of Other Governments
Brief: Nanoviricides Obtained Right Of First Refusal For All Antiviral Drug Developments